HUMA Return on Tangible Equity | Humacyte, Inc.

Humacyte, Inc. (HUMA) Return on Tangible Equity

2026-06-30: Return Tang Equity -309.44%.
2026-03-31: Return Tang Equity -839.56%.
2025-12-31: Return Tang Equity -1313.38%.
2025-09-30: Return Tang Equity 778.13%.

Complete source-backed return tang equity history.

Available history: 2020-12-31 to 2026-06-30
Data captured: 2026-09-04

Historical Return Tang Equity

Date	Return Tang Equity
2026-06-30	-309.44%
2026-03-31	-839.56%
2025-12-31	-1313.38%
2025-09-30	778.13%
2025-06-30	-1447.70%
2025-03-31	-215.48%
2024-12-31	282.33%
2024-09-30	239.90%
2024-06-30	493.73%
2024-03-31	-404.19%
2023-12-31	-817.78%
2023-09-30	-241.64%
2023-06-30	-145.09%
2023-03-31	-35.54%
2022-12-31	-10.23%
2022-09-30	28.94%
2022-06-30	19.72%
2022-03-31	-25.03%
2021-12-31	-21.67%
2021-09-30	-112.41%
2021-06-30	18.82%
2021-03-31	18.92%
2020-12-31	18.99%

Annual Return Tang Equity

Date	Return Tang Equity
2025-12-31	-1313.38%
2024-12-31	282.33%
2023-12-31	-817.78%
2022-12-31	-10.23%
2021-12-31	-21.67%
2020-12-31	18.99%

Similar stocks

Stock Name	Country	Market Cap	PE Ratio
Outlook Therapeutics, Inc. (OTLK)	United States	$0.162B	-4.90
Acumen Pharmaceuticals, Inc. (ABOS)	United States	$0.162B	-1.83
Tenaya Therapeutics, Inc. (TNYA)	United States	$0.140B	-1.60
Voyager Therapeutics, Inc. (VYGR)	United States	$0.173B	-1.99
PRECISION BIOSCIENCES INC (DTIL)	United States	$0.175B	-3.95
Caribou Biosciences, Inc. (CRBU)	United States	$0.134B	-1.79
Armata Pharmaceuticals, Inc. (ARMP)	United States	$0.132B
Neumora Therapeutics, Inc. (NMRA)	United States	$0.132B	-1.48
enGene Therapeutics Inc. (ENGN)		$0.129B	-0.92
Coherus Oncology, Inc. (CHRS)	United States	$0.182B	-1.63